The first study of its kind found ablation strategies used in normal hearts are safe, effective, and yield good results.
Payal Kohli, MD
A new study clears up a lingering question about the novel oral anticoagulants, VKAs, and risk of MI.
Results of the CABANA study (atrial fibrillation) are up for evaluation. How did the trial work and could it change your thoughts on AF treatment?
Brush up on your oral anticoagulation basics with answers to three key questions we posed to cardiologist and Patient Care board member Payal Kohli, MD.
And it's very good news for clinicians who routinely recite the pros/cons of direct oral anticoagulation to their patients with atrial fibrillation.
Nuts have proven, once again, that they are one of the leading heart-healthy foods.
The path to reducing risk of stroke in AF patients is far from straight and narrow. A case and 3 questions test your clinical navigation skills.
Post-procedure AF, once thought to be an artifact of healing, turns out to be a sign of significant risk, a new study finds.
Consider this case of a 92-year-old man who presents with permanent atrial fibrillation and multiple comorbidities. Should he be anticoagulated?
A 76-year-old woman with drug eluting stent placed post-STEMI will need an antiplatelet regimen. What would you recommend?